TRCT
HSCS icon

Tower Research Capital (TRC)’s Heart Test Laboratories HSCS Stock Holding History

Tower Research Capital (TRC)’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.94K Sell
1,568
-483
-24% -$990 ﹤0.01% 4451
2026
Q1 		$5.16K Buy
2,051
+542
+36% +$1.58K ﹤0.01% 4136
2025
Q4 		$4.66K Buy
1,509
+1,337
+777% +$3.97K ﹤0.01% 4191
2025
Q3 		$599 Sell
172
-493
-74% -$1.79K ﹤0.01% 4977
2025
Q2 		$2.49K Sell
665
-718
-52% -$2.51K ﹤0.01% 4641
2025
Q1 		$3.9K Buy
1,383
+1,283
+1,283% +$4.29K ﹤0.01% 4331
2024
Q4 		$382 Sell
100
-1,777
-95% -$6.1K ﹤0.01% 5301
2024
Q3 		$9.1K Buy
1,877
+1,301
+226% +$4.76K ﹤0.01% 3905
2024
Q2 		$3K Sell
576
-49
-8% -$389 ﹤0.01% 4940
2024
Q1 		$7.31K Buy
625
+502
+408% +$6.56K ﹤0.01% 4226
2023
Q4 		$2.11K Buy
+123
New +$3.03K ﹤0.01% 5273
2023
Q3 		– Sell
-9
Closed -$812 – 6058
2023
Q2 		$812 Sell
9
-16
-64% -$1.56K ﹤0.01% 5543
2023
Q1 		$2K Sell
25
-45
-64% -$6.08K ﹤0.01% 5356
2022
Q4 		$6K Buy
+70
New +$11K ﹤0.01% 4720
2022
Q3 		– Sell
-17
Closed -$3K – 6241
2022
Q2 		$3K Buy
+17
New +$3.29K ﹤0.01% 5378

Other funds holding HSCS

TA
TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Tower Research Capital (TRC)'s HSCS Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Heart Test Laboratories (HSCS) stake by 24% in Q2 2026, selling an estimated $990 and leaving 1,568 shares worth $3.94K. The position accounts for ﹤0.01% of the portfolio, ranked #4451.

Tower Research Capital (TRC) first reported a position in HSCS in Q2 2022 and has held it in 15 quarters since. The position peaked at $9.1K in Q3 2024. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,568 shares of Heart Test Laboratories worth $3.94K as of Q2 2026.
  • Tower Research Capital (TRC) sold 483 Heart Test Laboratories shares in Q2 2026, an estimated $990.
  • Heart Test Laboratories made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4451 holding.
  • Tower Research Capital (TRC) first reported a position in Heart Test Laboratories in Q2 2022 and has held it in 15 quarters since.
  • Tower Research Capital (TRC)'s Heart Test Laboratories position peaked at $9.1K in Q3 2024.
  • 16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.